QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
$1.11
-2.6%
$1.22
$0.84
$2.03
$42.32M0.99121,264 shs55,034 shs
CZX
Canada Zinc Metals
C$0.31
+∞
C$0.31
C$0.22
C$0.39
C$51.69MN/A238,645 shs118,500 shs
First Capital Realty Inc. stock logo
FCR
First Capital Realty
C$20.86
C$18.60
C$22.79
N/AN/A468,009 shs3.04 million shs
Grupo México, S.A.B. de C.V. stock logo
GMBXF
Grupo México
$6.02
-0.8%
$5.54
$4.02
$6.71
N/AN/A14,210 shs38,932 shs
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
+2.70%-10.24%-0.87%+1.79%-27.85%
CZX
Canada Zinc Metals
0.00%0.00%0.00%0.00%0.00%
First Capital Realty Inc. stock logo
FCR
First Capital Realty
0.00%0.00%0.00%0.00%0.00%
Grupo México, S.A.B. de C.V. stock logo
GMBXF
Grupo México
+0.30%-5.78%+11.34%+21.85%+17.14%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
1.3867 of 5 stars
3.50.00.00.00.03.31.3
CZX
Canada Zinc Metals
N/AN/AN/AN/AN/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/AN/AN/AN/AN/AN/A
Grupo México, S.A.B. de C.V. stock logo
GMBXF
Grupo México
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
3.00
Buy$7.00530.63% Upside
CZX
Canada Zinc Metals
N/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/AN/A
Grupo México, S.A.B. de C.V. stock logo
GMBXF
Grupo México
3.00
BuyN/AN/A

Current Analyst Ratings

Latest GMBXF, BOLT, CZX, and FCR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/22/2024
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$8.00
(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
$7.88M5.37N/AN/A$2.97 per share0.37
CZX
Canada Zinc Metals
N/AN/AN/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/AN/AN/AN/A
Grupo México, S.A.B. de C.V. stock logo
GMBXF
Grupo México
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
-$69.20M-$1.83N/AN/AN/A-878.58%-51.18%-37.81%5/9/2024 (Estimated)
CZX
Canada Zinc Metals
N/AN/A0.00N/AN/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/A0.00N/AN/AN/AN/AN/A5/1/2024 (Confirmed)
Grupo México, S.A.B. de C.V. stock logo
GMBXF
Grupo México
N/A$0.3318.24N/AN/AN/AN/AN/A

Latest GMBXF, BOLT, CZX, and FCR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2024N/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
C$0.29N/A-C$0.29N/AN/AN/A
3/21/2024Q4 2023
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
-$0.47-$0.47N/A-$0.47$1.97 million$2.09 million
2/6/2024Q4 2023
First Capital Realty Inc. stock logo
FCR
First Capital Realty
C$0.31C$0.81+C$0.50C$0.81N/AC$171.18 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
N/AN/AN/AN/AN/A
CZX
Canada Zinc Metals
N/AN/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/AN/AN/A
Grupo México, S.A.B. de C.V. stock logo
GMBXF
Grupo México
$0.081.25%N/A22.73%N/A

Latest GMBXF, BOLT, CZX, and FCR Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/15/2024
First Capital Realty Inc. stock logo
FCR
First Capital Realty
MonthlyC$0.074.14%4/29/20244/30/20245/15/2024
3/15/2024
First Capital Realty Inc. stock logo
FCR
First Capital Realty
MonthlyC$0.073/27/20243/28/20244/15/2024
2/6/2024
First Capital Realty Inc. stock logo
FCR
First Capital Realty
MonthlyC$0.072/28/20242/29/20243/15/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
0.15
5.17
5.17
CZX
Canada Zinc Metals
N/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/A
Grupo México, S.A.B. de C.V. stock logo
GMBXF
Grupo México
N/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
86.70%
CZX
Canada Zinc Metals
N/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/A
Grupo México, S.A.B. de C.V. stock logo
GMBXF
Grupo México
14.47%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
10038.13 million27.30 millionNot Optionable
CZX
Canada Zinc Metals
147,000166.73 millionN/ANot Optionable
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/ANot Optionable
Grupo México, S.A.B. de C.V. stock logo
GMBXF
Grupo México
31,362N/AN/ANot Optionable

GMBXF, BOLT, CZX, and FCR Headlines

SourceHeadline
Foreigner and Loverboy coming to Las CrucesForeigner and Loverboy coming to Las Cruces
msn.com - April 3 at 8:55 AM
Grupo Bafar Reports Fourth Quarter 2023 ResultsGrupo Bafar Reports Fourth Quarter 2023 Results
markets.businessinsider.com - February 16 at 11:55 AM
Grupo Mexico Q4 profit slides 19%Grupo Mexico Q4 profit slides 19%
finance.yahoo.com - February 4 at 10:08 AM
Grupo Mexico profit down 19% on slide in metal pricesGrupo Mexico profit down 19% on slide in metal prices
mining.com - February 2 at 12:36 PM
Grupo Mexico mulls Spanish copper mine acquisitionGrupo Mexico mulls Spanish copper mine acquisition
msn.com - January 13 at 12:57 AM
Grupo Mexico Considers Bid for First Quantum’s Spanish Copper MineGrupo Mexico Considers Bid for First Quantum’s Spanish Copper Mine
thedeepdive.ca - January 12 at 9:54 AM
Grupo Mexico weighs bid for First Quantums Spanish copper mineGrupo Mexico weighs bid for First Quantum's Spanish copper mine
lfpress.com - January 11 at 6:45 PM
Grupo Mexico considering bid for First Quantum mine in Spain - BloombergGrupo Mexico considering bid for First Quantum mine in Spain - Bloomberg
msn.com - January 11 at 1:02 PM
Mexico’s Grupo Carso acquires PetroBalMexico’s Grupo Carso acquires PetroBal
leadersleague.com - December 28 at 12:17 AM
GMBXF Dividend Yield GradeGMBXF Dividend Yield Grade
seekingalpha.com - December 28 at 12:17 AM
Grupo Mexico buys 60% of two companies involved in US-Mexico tradeGrupo Mexico buys 60% of two companies involved in US-Mexico trade
msn.com - December 26 at 6:16 PM
Tri-Rail awaits green light to start operating from Brightlines MiamiCentralTri-Rail awaits green light to start operating from Brightline's MiamiCentral
bizjournals.com - December 23 at 12:16 PM
Grupo Mexico (GMEXICOB) Earnings Dates & ReportsGrupo Mexico (GMEXICOB) Earnings Dates & Reports
investing.com - November 27 at 4:24 PM
Southern Copper cut at Morgan Stanley on lower production view, higher cash costsSouthern Copper cut at Morgan Stanley on lower production view, higher cash costs
msn.com - November 27 at 4:24 PM
Grupo Mexico SAB de CVs Dividend AnalysisGrupo Mexico SAB de CV's Dividend Analysis
finance.yahoo.com - November 21 at 8:11 AM
Grupo Mexico SAB de CV GMEXICOBGrupo Mexico SAB de CV GMEXICOB
morningstar.com - November 7 at 10:34 AM
Grupo Mexico SAB de CV GMBXFGrupo Mexico SAB de CV GMBXF
morningstar.com - November 5 at 9:34 AM
Copper miner Grupo Mexico posts boost in Q3 profit amid strong salesCopper miner Grupo Mexico posts boost in Q3 profit amid strong sales
reuters.com - October 24 at 11:01 PM
Grupo Mexico posts boost in Q3 profit amid strong salesGrupo Mexico posts boost in Q3 profit amid strong sales
mining.com - October 24 at 6:00 PM
Grupo Mexico being pushed to resume cleanup of 2014 mine spillGrupo Mexico being pushed to resume cleanup of 2014 mine spill
mining.com - October 20 at 11:39 PM
Grupo Mexico proposes work group to address Sonora river contaminationGrupo Mexico proposes work group to address Sonora river contamination
mining.com - October 19 at 2:32 PM
Mexico blames Grupo Mexico for 2014 toxic spill, wants new cleanup planMexico blames Grupo Mexico for 2014 toxic spill, wants new cleanup plan
reuters.com - October 12 at 10:55 PM
Mexico govt blames Grupo Mexico for 2014 toxic spill, wants new cleanup planMexico govt blames Grupo Mexico for 2014 toxic spill, wants new cleanup plan
theprint.in - October 12 at 5:55 PM
Mexico govt files complaint against Grupo Mexico over 2014 spill -ministerMexico govt files complaint against Grupo Mexico over 2014 spill -minister
theprint.in - October 12 at 12:54 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Bolt Biotherapeutics logo

Bolt Biotherapeutics

NASDAQ:BOLT
Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer. The company's lead product candidate BDC-1001, which is in clinical development for the treatment of patients with human epidermal growth factor receptor 2- positive solid tumors, including breast, colorectal, endometrial, and gastroesophageal cancer. It is also developing BDC-3042, an agonist antibody targeting Dectin-2 for range of tumors, such as head and neck, non-small cell lung, ovarian, triple-negative breast, and other cancer. The company has collaboration agreements with Toray Industries, Genmab A/S, Innovent Biologics, Inc., Bristol-Myers Squibb, and F. Hoffmann-La Roche Ltd; and license agreement with Stanford University. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood City, California.

Canada Zinc Metals

CVE:CZX
Canada Zinc Metals Corp. explores for and evaluates mineral resource properties in Canada. The company primarily explores for zinc-lead-silver base metals deposits. Its flagship property is the Akie property that consists of 46 mineral claims, which cover approximately 116 square kilometers, located in the Paleozoic Selwyn Basin, British Columbia. The company was formerly known as Mantle Resources Inc. and changed its name to Canada Zinc Metals Corp. in September 2008. Canada Zinc Metals Corp. was incorporated in 1988 and is headquartered in Vancouver, Canada.
First Capital Realty logo

First Capital Realty

TSE:FCR
Grupo México logo

Grupo México

OTCMKTS:GMBXF
Grupo México, S.A.B. de C.V. engages in copper production, cargo transportation, and infrastructure businesses worldwide. The company operates through Mining, Transportation, and Infrastructure divisions. The Mining division explores for copper, silver, molybdenum, zinc, sulfuric acid, gold, and selenium. It owns interests in 14 underground and open pit mines, and 8 exploration projects in Mexico, Peru, the United States, Argentina, Chile, Ecuador, and Spain. The Transportation division offers railroad transportation services, including general and intermodal freight services by railroad; passenger transportation services; and auxiliary terminal management and intra-terminal hauling services. This division provides railroad services for the agriculture, automotive, cement, energy, intermodal, metals and minerals, industrial products, and chemical and fertilizer sectors. It operates a railroad network of 11,137 km across 24 states in Mexico. The Infrastructure division offers land and ocean drilling services; and engineering services. It also generates energy through a combined cycle plant and wind farm; and constructs, operates, and maintains Salamanca-León highway and Silao Bypas. Grupo México, S.A.B. de C.V. was founded in 1890 and is based in Mexico City, Mexico.